BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coffey JW, Gaiha GD, Traverso G. Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. Annu Rev Pharmacol Toxicol 2021;61:517-40. [PMID: 32466690 DOI: 10.1146/annurev-pharmtox-030320-092348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hameed SA, Paul S, Dellosa GKY, Jaraquemada D, Bello MB. Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies. NPJ Vaccines 2022;7:71. [PMID: 35764661 DOI: 10.1038/s41541-022-00485-x] [Reference Citation Analysis]
2 Angulo C, Sanchez V, Delgado K, Monreal-Escalante E, Hernández-Adame L, Angulo M, Tello-Olea M, Reyes-Becerril M. Oral organic nanovaccines against bacterial and viral diseases. Microb Pathog 2022;169:105648. [PMID: 35728750 DOI: 10.1016/j.micpath.2022.105648] [Reference Citation Analysis]
3 Lockhart A, Mucida D, Parsa R. Immunity to enteric viruses. Immunity 2022;55:800-18. [PMID: 35545029 DOI: 10.1016/j.immuni.2022.04.007] [Reference Citation Analysis]
4 Coffey JW, van der Burg NMD, Rananakomol T, Ng H, Fernando GJP, Kendall MAF. An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202100151] [Reference Citation Analysis]
5 Jawalagatti V, Kirthika P, Hewawaduge C, Park JY, Yang MS, Oh B, So MY, Kim B, Lee JH. A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine. Front Immunol 2022;13:811802. [PMID: 35250985 DOI: 10.3389/fimmu.2022.811802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zainutdinov SS, Sivolobova GF, Loktev VB, Kochneva GV. [Mucosal immunity and vaccines against viral infections]. Vopr Virusol 2022;66:399-408. [PMID: 35019246 DOI: 10.36233/0507-4088-82] [Reference Citation Analysis]
7 Page S, Khan T, Kühl P, Schwach G, Storch K, Chokshi H. Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery Technologies. Annu Rev Pharmacol Toxicol 2022;62:341-63. [PMID: 34990203 DOI: 10.1146/annurev-pharmtox-052120-093517] [Reference Citation Analysis]
8 Vaernewyck V, Arzi B, Sanders NN, Cox E, Devriendt B. Mucosal Vaccination Against Periodontal Disease: Current Status and Opportunities. Front Immunol 2021;12:768397. [PMID: 34925337 DOI: 10.3389/fimmu.2021.768397] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Jain S, Venkataraman A, Wechsler ME, Peppas NA. Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic. Adv Drug Deliv Rev 2021;179:114000. [PMID: 34637846 DOI: 10.1016/j.addr.2021.114000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Chu JN, Traverso G. Foundations of gastrointestinal-based drug delivery and future developments. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34785786 DOI: 10.1038/s41575-021-00539-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Murtaza G. Recent strategies driving oral biologic administration. Expert Rev Vaccines 2021;:1-15. [PMID: 34612121 DOI: 10.1080/14760584.2021.1990044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ivanova E. Yeasts in nanotechnology-enabled oral vaccine and gene delivery. Bioengineered 2021;12:8325-35. [PMID: 34592900 DOI: 10.1080/21655979.2021.1985816] [Reference Citation Analysis]
13 Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology. Int Immunopharmacol 2021;90:107247. [PMID: 33307513 DOI: 10.1016/j.intimp.2020.107247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]